Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Dr Reddys Laboratories Ltd Financial Statements & Historical Data

Updated NSE: DRREDDYBSE: 500124
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 29 September 2026, 8:32 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price1,252₹ per share
Reported P/E32.4Times
Book value per share454₹ per share
Reported ROCE13.0 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 29 September 2026, 8:32 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap1,04,365 Cr.
Current Price1,252
High / Low1,415/1,080
Stock P/E32.4
Book Value454
Dividend Yield0.64 %
ROCE13.0 %
ROE11.2 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Dr Reddys Laboratories Ltd 1,04,365 Cr. 1,252 1,415/1,08032.4 4540.64 %13.0 %11.2 % 1.00
Mankind Pharma Ltd 1,04,950 Cr. 2,545 2,642/1,91046.4 3970.04 %13.7 %13.8 % 1.00
Laurus Labs Ltd 1,06,859 Cr. 1,979 2,055/827122 97.30.10 %16.0 %15.2 % 2.00
Cipla Ltd 1,11,012 Cr. 1,379 1,673/1,16631.0 4260.94 %15.5 %11.6 % 2.00
Aurobindo Pharma Ltd 97,538 Cr. 1,698 1,740/1,06625.8 6520.24 %12.9 %10.1 % 1.00
Industry Average17,958.89 Cr1,272.7356.24211.600.38%26.16%16.59%6.06

All Competitor Stocks of Dr Reddys Laboratories Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 6,7586,9037,2377,1147,6968,0388,3818,5288,5728,8288,7537,5468,100
Expenses 4,6964,8945,2145,2835,5665,9626,1086,5306,3986,8186,8667,1647,240
Operating Profit 2,0622,0082,0231,8312,1302,0762,2731,9982,1742,0101,888382860
OPM % 31%29%28%26%28%26%27%23%25%23%22%5%11%
Other Income 178319219201193314154528290330271480356
Interest 3735395960768266839194106126
Depreciation 353376374368381397471455476505521557537
Profit before tax 1,8501,9171,8291,6051,8831,9171,8742,0051,9051,7451,543200553
Tax % 24%23%24%18%26%30%25%21%26%23%23%-11%21%
Net Profit 1,4051,4821,3811,3101,3921,3421,4041,5871,4101,3371,190221436
EPS in Rs 16.8717.7716.5615.7016.6915.0516.9419.0916.9916.1414.502.655.32

Last Updated: September 29, 2026, 11:06 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 27, 2026, 1:32 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 13,41515,02315,56814,19614,28115,44817,51719,04821,54524,67028,01132,64433,70033,228
Expenses 10,16411,51511,98311,72411,93012,27015,04015,17317,77818,20020,07824,09727,24728,088
Operating Profit 3,2513,5083,5852,4722,3513,1782,4773,8743,7686,4707,9338,5476,4545,140
OPM % 24%23%23%17%16%21%14%20%17%26%28%26%19%15%
Other Income 1702602951721553816703355559719091,1191,3721,437
Interest 12710883637989989796143171283374416
Depreciation 6487609391,0271,0771,1351,1631,2291,1651,2501,4701,7042,0592,119
Profit before tax 2,6462,9002,8591,5541,3502,3361,8862,8843,0616,0487,2017,6805,3934,041
Tax % 26%19%26%19%32%17%-7%32%29%25%23%25%23%
Net Profit 1,9632,3362,1311,2929471,9502,0261,9522,1824,5075,5785,7254,1583,183
EPS in Rs 23.0827.4324.9815.5911.4123.4924.3823.4726.2354.1466.8767.7750.2738.61
Dividend Payout % 16%15%16%26%35%17%21%21%23%15%12%12%16%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)19.00%-8.78%-39.37%-26.70%105.91%3.90%-3.65%11.78%106.55%23.76%2.64%-27.37%
Change in YoY Net Profit Growth (%)0.00%-27.78%-30.60%12.67%132.62%-102.02%-7.55%15.44%94.77%-82.79%-21.13%-30.01%

Dr Reddys Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Last Updated: September 5, 2025, 3:10 am

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 2, 2026, 5:30 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 858583838383838383838384
Reserves 9,76812,48412,17912,48913,94115,51617,55819,12923,20328,17133,46637,808
Borrowings 4,3143,3524,9185,0713,8382,2103,0313,3841,3472,0024,6777,734
Other Liabilities 4,2904,4084,4744,7064,5575,4145,9157,1497,5768,5239,79710,951
Total Liabilities 18,45720,33021,65422,34922,41823,22326,58829,74632,20938,78048,02356,577
Fixed Assets 5,3776,5636,9316,9687,1916,8508,2068,1229,21910,42618,22622,063
CWIP 5297723,3243,4702,9341,5351,5651,2931,0301,4192,4661,460
Investments 2,2483,8332,1102,2982,5872,6782,2122,6164,9864,9304,0515,285
Other Assets 10,3039,1629,2909,6129,70712,16014,60517,71516,97422,00423,28027,768
Total Assets 18,45720,33021,65422,34922,41823,22326,58829,74632,20938,78048,02356,577
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 2,5243,2632,1441,8032,8702,9843,5702,8115,8884,5434,6435,674
Cash from Investing Activity + -2,370-1,610-1,890-1,483-769-495-2,255-2,565-4,109-4,034-5,785-6,425
Cash from Financing Activity + -433-1,700-369-444-2,133-2,516-30-242-2,686-3761,891829
Net Cash Flow -280-47-114-124-31-271,2863-90713374978
Free Cash Flow 1,0092,0659267132,2482,4122,3231,2384,0091,9081,3272,004
CFO/OP 88%111%110%88%106%149%107%94%108%83%78%109%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow1,009.002,065.00926.00713.002,248.002,412.002,323.001,238.004,009.001,908.001,327.002,004.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 9010097981049410595113107105101
Inventory Days 271248248282263273230273250232283260
Days Payable 100848810412111110010911110811697
Cash Conversion Cycle 261264257275246256235259252231271264
Working Capital Days 322634-1439655957618411869
ROCE %25%22%19%9%8%13%11%16%14%27%27%23%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 26.66%26.65%26.65%26.65%26.64%26.64%26.64%26.64%26.64%26.64%26.63%26.63%
FIIs 28.19%28.62%29.13%27.68%27.53%26.85%25.75%25.33%24.69%22.34%21.14%20.67%
DIIs 21.04%18.65%18.31%20.72%21.48%22.89%25.63%26.73%27.99%30.44%30.72%31.75%
Public 23.93%25.89%25.73%24.78%24.20%23.46%21.69%21.04%20.45%20.33%21.27%20.76%
Others 0.18%0.18%0.17%0.17%0.16%0.16%0.29%0.26%0.25%0.25%0.24%0.20%
No. of Shareholders 2,43,4452,57,7942,55,5002,67,6943,10,4034,03,6694,59,6054,51,9294,49,2164,55,2434,49,6654,46,086
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Parag Parikh Flexi Cap Fund 14,083,029 1.28 1715.4513,125,5452026-02-23 04:05:167.29%
ICICI Prudential Value Fund 11,845,856 2.39 1442.94N/AN/AN/A
Nippon India Large Cap Fund 5,357,429 1.3 652.59N/AN/AN/A
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund 3,973,068 7.27 483.965,036,7282026-01-25 06:49:26-21.12%
Nippon India Pharma Fund 3,916,074 6.06 477.02550,0302025-09-18 02:15:08611.97%
ICICI Prudential Large Cap Fund 3,655,647 0.58 445.29N/AN/AN/A
Nippon India Small Cap Fund 3,172,198 0.59 386.41N/AN/AN/A
ICICI Prudential Balanced Advantage Fund 3,166,610 0.55 385.723,177,1742026-01-25 06:49:26-0.33%
Mirae Asset Large Cap Fund 3,124,889 0.94 380.642,870,1162026-02-23 01:16:548.88%
ICICI Prudential Multi Asset Fund 2,846,687 0.43 346.752,909,8122026-01-25 06:49:26-2.17%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.005.005.005.005.00
Basic EPS (Rs.) 67.89335.22271.47131.57117.67
Diluted EPS (Rs.) 67.79334.59270.90131.21117.34
Cash EPS (Rs.) 88.82421.65343.37196.96188.25
Book Value[Excl.RevalReserv]/Share (Rs.) 402.271693.931397.721154.591060.20
Book Value[Incl.RevalReserv]/Share (Rs.) 402.271693.931397.721154.591060.20
Revenue From Operations / Share (Rs.) 391.411679.321480.771294.781144.68
PBDIT / Share (Rs.) 115.64529.22444.45255.53250.08
PBIT / Share (Rs.) 95.21441.09369.41185.51176.23
PBT / Share (Rs.) 91.82430.83360.83179.75170.40
Net Profit / Share (Rs.) 68.39333.52268.32126.94114.40
NP After MI And SOA / Share (Rs.) 67.81334.41270.55131.16117.28
PBDIT Margin (%) 29.5431.5130.0119.7321.84
PBIT Margin (%) 24.3226.2624.9414.3215.39
PBT Margin (%) 23.4525.6524.3613.8814.88
Net Profit Margin (%) 17.4719.8618.129.809.99
NP After MI And SOA Margin (%) 17.3219.9118.2710.1210.24
Return on Networth / Equity (%) 16.8519.7419.3511.3511.06
Return on Capital Employeed (%) 21.8125.1325.9515.4415.84
Return On Assets (%) 11.4414.3513.967.337.33
Long Term Debt / Equity (X) 0.010.010.000.010.02
Total Debt / Equity (X) 0.120.050.040.160.15
Asset Turnover Ratio (%) 0.730.780.790.560.59
Current Ratio (X) 1.922.592.381.821.80
Quick Ratio (X) 1.371.921.811.301.24
Inventory Turnover Ratio (X) 4.850.800.840.851.03
Dividend Payout Ratio (NP) (%) 11.7811.9111.0418.9921.24
Dividend Payout Ratio (CP) (%) 9.059.438.6412.3813.03
Earning Retention Ratio (%) 88.2288.0988.9681.0178.76
Cash Earning Retention Ratio (%) 90.9590.5791.3687.6286.97
Interest Coverage Ratio (X) 34.0951.5951.8544.3942.90
Interest Coverage Ratio (Post Tax) (X) 21.1633.5132.3023.0520.62
Enterprise Value (Cr.) 97515.87102592.5076382.9972310.8675755.28
EV / Net Operating Revenue (X) 2.993.663.103.363.98
EV / EBITDA (X) 10.1111.6210.3217.0118.20
MarketCap / Net Operating Revenue (X) 2.923.673.123.333.94
Retention Ratios (%) 88.2188.0888.9581.0078.75
Price / BV (X) 2.843.633.313.734.26
Price / Net Operating Revenue (X) 2.923.673.123.333.94
EarningsYield 0.050.050.050.030.02
Advertisements
Explore Industry-wise Company financial data